Interesting trends were observed in the subgroup analyses of the phase 3 uproleselan study in relapsed or refractory acute ...
Background: Acute myeloid leukemia (AML) is a hematologic tumor with poor prognosis and significant clinical heterogeneity. By integrating transcriptomic data, single-cell RNA sequencing data and ...